Health
Study shows 90.7% efficacy for the BNT162b2 COVID vaccine in 5-11 year-olds – News-Medical.Net
A new study evaluates the safety, immunogenicity, and efficacy of the BNT162b2 in children who were 5 to 11 years of age.
Vaccination against coronavirus disease 2019 (COVID-19) has been considered to be the most effective way to reduce the mortality and morbidity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Several vaccine candidates have…
Continue Reading
-
Noosa News10 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
Noosa News24 hours agoPolice charge second man over alleged assault in Gold Coast car seller on Facebook’s Marketplace
-
General19 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Noosa News24 hours agoBIGSOUND Is Back For 2025 With Over 130 Emerging Artists